Genetic engineering technologies can be used both to create transgenic mosquitoes carrying antipathogen effector genes targeting human malaria parasites and to generate gene-drive systems capable of introgressing the genes throughout wild vector populations. We developed a highly effective autonomous Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein 9 (Cas9)-mediated gene-drive system in the Asian malaria vector Anopheles stephensi, adapted from the mutagenic chain reaction (MCR). This specific system results in progeny of males and females derived from transgenic males exhibiting a high frequency of germ-line gene conversion consistent with homology-directed repair (HDR). This system copies an ∼17-kb construct from its site of insertion to its homologous chromosome in a faithful, site-specific manner. Dual anti-Plasmodium falciparum effector genes, a marker gene, and the autonomous gene-drive components are introgressed into ∼99.5% of the progeny following outcrosses of transgenic lines to wild-type mosquitoes. The effector genes remain transcriptionally inducible upon blood feeding. In contrast to the efficient conversion in individuals expressing Cas9 only in the germ line, males and females derived from transgenic females, which are expected to have drive component molecules in the egg, produce progeny with a high frequency of mutations in the targeted genome sequence, resulting in near-Mendelian inheritance ratios of the transgene. Such mutant alleles result presumably from nonhomologous end-joining (NHEJ) events before the segregation of somatic and germ-line lineages early in development. These data support the design of this system to be active strictly within the germ line. Strains based on this technology could sustain control and elimination as part of the malaria eradication agenda.
Plasmodium falciparum | MCR | eradication | transgenesis | CRISPR E fforts in the ongoing campaign to eradicate malaria show mixed success. The World Health Organization reports that malaria mortality continues to decrease and estimates that ∼3.3 million lives have been saved since 2001 as a result of using new drugs, personal protection, environmental modification, and other measures (1) (2) (3) . Although these gains are encouraging, there were still ∼580,000 deaths globally in 2014 (3), a statistic that supports the continued application of proven existing control and treatment methods while highlighting the pressing need for strategic development and deployment of new tools.
Prevention of parasite transmission by vector mosquitoes has always played a major role in malaria control (4, 5) . However, the challenges of vector control mirror those of malaria eradication in general and include the heterogeneity and complexity of transmission dynamics and the difficulties in sustaining control practices (6, 7) . Genetic approaches that result in altering vector populations in such a way as to eliminate their ability to transmit parasites to humans (population modification) can contribute to sustainable control and elimination by providing barriers to parasite and competent vector reintroduction, and allow resources to be directed to new sites while providing confidence that treated areas will remain malaria-free (5, 7) .
We and others are pursuing a population-modification approach that involves the introduction of genes that confer a parasite-resistance phenotype to mosquitoes that otherwise would be fully capable of transmitting the pathogens (8) (9) (10) (11) (12) (13) . The expectation is that the introgression of such an effector gene at a high enough frequency in a vector population would decrease or eliminate transmission and result in measurable impacts on morbidity and mortality (14) . Critical to this approach are the development of a gene that confers resistance to the transmission of the parasites, transgenesis tools for introducing the genes into mosquito strains, and a mechanism to spread the genes at epidemiologically significant rates into the target populations. Working with Anopheles stephensi, a vector of malaria in the Indian subcontinent (15) , we now have demonstrated proof of principle for all of these components.
An. stephensi is both an established and emerging malaria vector. It is estimated to be responsible for ∼12% of all transmission in India, mostly in urban settings, accounting for a total of ∼106,000 clinical cases in 2014 (3, (16) (17) (18) , and also may be responsible for recent epidemic outbreaks in Africa (19) . Laboratory strains of An.
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Malaria continues to impose enormous health and economic burdens on the developing world. Novel technologies proposed to reduce the impact of the disease include the introgression of parasite-resistance genes into mosquito populations, thereby modifying the ability of the vector to transmit the pathogens. Such genes have been developed for the human malaria parasite Plasmodium falciparum. Here we provide evidence for a highly efficient gene-drive system that can spread these antimalarial genes into a target vector population. This system exploits the nuclease activity and target-site specificity of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system, which, when restricted to the germ line, copies a genetic element from one chromosome to its homolog with ≥98% efficiency while maintaining the transcriptional activity of the genes being introgressed.
stephensi are transformed efficiently with transposable elements facilitating analyses of transgene expression in diverse genomic locations (20) . Site-specific integration technologies adapted to this species allow integrations of exogenous DNA into the mosquito genome at locations with little or no impact on fitness (11, 21) . Furthermore, a dual antiparasite effector gene was developed based on the single-chain antibodies (scFvs) m1C3 and m2A10 that target the human malaria parasite Plasmodium falciparum ookinete protein Chitinase 1 and the circumsporozoite protein (CSP), respectively (10, 22, 23) . Transgenic An. stephensi adult females expressing m1C3 and m2A10 had no P. falciparum sporozoites (the infectious stage of these parasites) in their salivary glands under infection conditions expected in the field, and therefore were incapable of transmitting parasites (11) .
Research on mechanisms for introducing antipathogen effector genes into target populations supports a number of approaches, including inundative releases and those based on gene-drive systems (24) . Inundative approaches rely on releases of engineered mosquitoes in numbers substantially exceeding those of the local population to drive gene frequencies high enough to have an epidemiological impact. Inundative releases of chemically or radiationtreated insects were successful in population suppression of mosquitoes using sterile insect technologies (25) . However, modeling of gene-drive systems, which exceed rates of Mendelian inheritance, shows a more rapid population-level transformation with fewer releases than inundative approaches (24) , and this would result in sustainable local malaria elimination at much reduced costs (7) .
We show here that a gene-drive system using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein 9 (Cas9)-mediated homology-directed repair (HDR) adapted from a highly efficient system, mutagenic chain reaction (MCR), developed in the fruit fly Drosophila melanogaster (26) drives target-specific gene conversion at ≥99.5% efficiency in transgene heterozygotes of An. stephensi. The drive system as designed works in both the male and female germ lines of mosquitoes derived from transgenic males. Cas9-mediated gene targeting also is evident in the somatic cells of embryos derived from transgenic females. The system can carry a relatively large set of genes (∼17 kb in length), and these are transcriptionally active following movement. Strains based on this technology could have a major role in sustaining malaria control and elimination as part of the eradication agenda.
Results
Assembly, Microinjection, and Selection of Transgenic Progeny. The structure of the gene-drive plasmid, pAsMCRkh2, is based on a previous autocatalytically propagating element design (26) and targets its insertion into the locus encoding the kynurenine hydroxylase (kynurenine monooxygenase) enzyme (Fig. 1) . The target gene is located autosomally on 3L of the An. stephensi linkage map (15) , and we refer to it as kynurenine hydroxylase white (kh w ) to indicate orthology with a gene in Aedes aegypti, which has a recessive white-eye phenotype (27) (28) (29) . The pAsMCRkh2 construct has the following elements: (i) an An. stephensi codon-optimized Cas9 endonuclease-encoding DNA flanked by the putative promoter, 5′-and 3′-end nucleotide sequences of the An. stephensi vasa gene (ASTE003241), intended to drive the expression of the nuclease in both male and female germ lines; (ii) a putative An. stephensi U6A gene (ASTE015697) promoter directing the expression of a guide RNA (gRNA) targeting the An. stephensi kh w gene at a site (designated kh2) immediately adjacent to two known mutations in the Ae. aegypti orthologous gene that cause visible eye phenotypes (28, 29) ; (iii) a 3xP3-DsRed gene (30) , which expresses the DsRed dominant fluorescence marker visible in larval photoreceptors as well as nonpigmented adult eyes (Fig. 2) ; (iv) dual antipathogen effector genes (m2A10-m1C3) targeting P. falciparum (10, 11) ; and (v) DNA fragments ∼1 kb in length each that are homologous to the An. stephensi kh w locus immediately adjacent to the 5′ and 3′ ends of the kh2 target cut site. The resulting plasmid is a total of ∼21 kb in length with 16,625 bp comprising the components ("cargo") targeted for insertion at the An. stephensi kh w locus. A total of 680 G 0 wild-type embryos of the Indian strain of An. stephensi (15) was injected with a solution containing 100 ng/μL each of the pAsMCRkh2 plasmid, Cas9 protein, Cas9 doublestranded RNAs (dsRNAs), and Ku70 dsRNA. The rationale for including the dsRNAs was to silence expression of the incoming Cas9 gene (dsCas9) carried on the plasmid and to reduce activity of the nonhomologous end-joining (NHEJ) pathway (dsKU70) (31) to favor HDR-mediated insertion of the pAsMCRkh2 cargo. Genomic integration of the transgene was achieved by the coinjected Cas9 protein together with the kh2 gRNA encoded on the (28) and square (29) . The plasmid, AsMCRkh2 (Bottom), carries promoter and coding sequences comprising vasa-Cas9 and the U6A-kh2 gRNA genes (U6A gRNA) linked to the dual scFv antibody cassette (m2A10-m1C3) conferring resistance to P. falciparum (11) and the dominant eye marker gene (DsRed) inserted between regions of homology (dark red boxes) from the An. stephensi kh w locus that directly abut the U6A-kh2 gRNA cut site. The black lines represent kh w intron sequences, and the gray lines indicate plasmid DNA sequences. Following gRNA-directed cleavage by the Cas9-kh2 gRNA nuclease complex at the kh2 target site (green arrowhead), homology-directed repair (HDR) leads to precise insertion of the AsMCRkh2 cargo (m2A10-m1C3, DsRed, vasa-Cas9, U6A gRNA) into the genomic kh w locus via HDR events somewhere within the regions of homology (pink-shaded quadrilaterals). Plasmid sequences are not integrated. (B) Gene amplification analysis confirms integration of the AsMCRkh2 cargo in genomic DNA prepared from the two G 1 male transformants (10.1 and 10.2) that were positive for the DsRed eye-marker phenotype. Both males carry left and right junction fragments of the AsMCRkh2 cargo with the supplied kh w regions of homology (KM1F1/Vg5′R1 and U6F1/KM2R1 primer combinations, respectively). An amplicon corresponding to the wild-type kh w locus (505/557 primer pairs) confirms that these mosquitoes were heterozygous in some of their cells. Wild-type (wt) control DNA supports amplification only of the wild-type kh w locus (505/557 primers). (C ) Gene amplification analysis confirms site-specific integration of the AsMCRkh2 construct at the kh w locus using primers located outside of the genomic sequence included in the AsMCRkh2 cassette (the left integration junction fragment amplified with primers G1F2/Vg5′R2, and the right junction fragment amplified with primers U6F1/G2R2). Wild-type control DNA did not support amplification of these hybrid fragments. Numbers refer to the length in nucleotides of the amplified fragments. Amplicon primary structure was verified by DNA sequencing (SI Appendix, Fig. S1 ).
plasmid. A total of 122 and 129 adult males and females, respectively (37%), survived to the adult stage. Adults were assigned to 22 male-founder and 9 female-founder pools and outcrossed to wild-type adults of the opposite sex. Two males positive for DsRed fluorescence (DsRed + ), designated 10.1 and 10.2, were recovered following screening of 25,712 G 1 larvae.
Efficient Autonomous Gene Drive of the AsMCRkh2 Construct. A notable difference in the inheritance patterns of the DsRed marker gene was observed in the G 2 progeny of the 10.1 and 10.2 G 1 males following outcrosses to wild-type females (SI Appendix, Table S1 ). Male 10.1 produced all DsRed + adult progeny (n = 14), whereas male 10.2 produced 44% DsRed + progeny (57 of 129). Although the number of 10.1 G 2 progeny is too small for statistical analysis, the data are consistent with drive of the DsRed dominant marker gene. However, the line 10.2 DsRed + ratios were not significantly different from those expected of random Mendelian segregation (Χ 2 = 1.744, df = 1; P = 0.1866). Target-specific integration of the transgene into the kh w locus was verified in each of the G 1 founder males by gene amplification using oligonucleotide primers complementary to DNA within the construct and outside the regions of homology included in the construct ( Fig. 1 and SI Appendix, Table S2 ). Sequencing of the ends of the diagnostic amplicons spanning both sides of the insertion within the kh w -coding region confirmed the structure and precise integrity of the junctions of the transgene and genomic DNAs (SI Appendix, Fig. S1 ). DsRed + G 2 males and females derived from 10.1 and 10.2 G 1 founders were outcrossed individually and in batch matings to wild-type mosquitoes, and G 3 larval progeny were scored for DsRed. Extreme non-Mendelian DsRed segregation patterns were evident in both 10.1 and 10.2 G 2 male and female outcrosses (SI Appendix, Tables S3 and S4 ) were recovered from femalefounder families, and gene amplification and sequencing confirmed that they have target site-specific deletions in the kh w locus consistent with Cas9-mediated NHEJ (SI Appendix, Fig. S2 ).
Non-Mendelian segregation patterns consistent with gene drive were also seen in the eye-color phenotypes of lines 10.1 and 10.2 G 3 larvae that survived to adults (Table 1 (Fig. 2) . Additionally, a number of G 3 progeny from female-founder families scored as DsRed + /kh w− phenotype (positive for DsRed/white eye color) were modified by eye coloring ("coloring"; SI Appendix, Table S6 ). This coloring is consistent with partial cell-nonautonomous rescue of the white-eye phenotype by wild-type expression of the gene in a somatic location other than the eye or a hypomorphic allele generated by NHEJ. The frequency of this coloring phenotype in the 10 families in which it was explicitly scored varied from 5 to 32%, with an average of ∼17%. The nondrive phenotypic classes were mosquitoes negative for DsRed with a wild-type eye color (DsRed − /kh w+ ) and the rare mosquitoes negative for DsRed with a white eye color (DsRed − /kh w− ) seen in the larvae ( Fig. 2 and Table 1 ).
The numerical summaries of the G 3 adult phenotypes confirm the non-Mendelian segregation patterns consistent with highly efficient gene drive. gene-conversion rate. This latter value is derived from a formula: conversion rate = 2(X − 0.5N)/N, where N is the total number of mosquitoes and X is the number of DsRed-positive individuals, which accounts for the fact that 50% of the progeny would be expected to inherit the transgene by traditional Mendelian segregation (26) . These combined data support the conclusion that Cas9-mediated gene conversion resulting from HDR can occur at near-complete efficiency in the germ- ) for the transgene cargo. However, this ratio still deviates from that expected by Mendelian segregation alone (X 2 = 33.123, df = 1; P < 0.0001). We interpret these results to indicate that the progeny of pAsMCRkh2 females often inherit "indel" mutations presumably generated via the NHEJ pathway in the male-derived kh w allele. However, the excess of DsRed + larvae among the progeny is consistent with a fraction of the incoming chromosomes also having been converted by HDR.
The 
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w− G 3 founder mosquitoes was used with gene-specific primers to amplify the kh2 target portion of the kh w gene. Diagnostic fragments of 754 bp were seen in each of the samples, indicating that these mosquitoes had chromosomes without the large ∼17-kb transgene cargo inserted into it (SI Appendix, Fig. S3 ). These fragments must include mutant alleles, because the eye phenotype of each mosquito from which the DNA was derived was white (kh w− 4 progeny, amounting to ∼98.6% efficiency of inheritance of the cargo and corresponding to a 97.2% rate of gene conversion. These data provide strong support for the conclusion that Cas9-mediated gene drive continues 
. † Crosses are listed in Fig. 3 and SI Appendix, Tables S10 and S11.
to occur efficiently and in a multigenerational fashion in the germ line of these transgenic mosquitoes.
The reduced germ-line transmission of the AsMCRkh2 cargo in G 4 larvae derived from DsRed + /kh w− G 3 parents described above also was evident in the adult phenotypes. The ratio (1.27:1) of DsRed + /DsRed − phenotypes of the corresponding adult G 4 progeny derived from DsRed + /kh w− males (Table 2 ; crosses 2 and 4; SI Appendix, Tables S10 and S11) still deviates from that expected by Mendelian segregation alone (Χ 2 = 16.404, df = 1; P < 0.0001). Similarly, G 4 adult progeny of DsRed + /kh w− females (Table 2 ; crosses 1 and 3; SI Appendix, Tables S10 and S11) had a DsRed + /DsRed − phenotypic ratio of 1.48:1, also significantly different from that expected solely by Mendelian segregation (Χ 2 = 11.014, df = 1; P = 0.0009). However, in contrast to the crosses with male G 3 parents in which all DsRed − progeny were kh w+ , 41.2% (49/119) of the DsRed − progeny of G 3 females had white eyes (kh w− ). These data provide further support for the conclusion that Cas9-gRNA complexes perdure in eggs derived from transgenic cargobearing females. The relatively fewer number of progeny derived from the DsRed + /kh w− females may be indicative of a load associated with this genotype.
The differences and consequences of the maternal effects on gene drive are summarized in Fig. 3 
w+ females to wild-type males produces a high frequency of DsRed + /kh w− along with somatic mosaicism. Continued outcrossing of these individuals to wild-type mosquitoes results in progeny inheriting the AsMCRkh2 cargo in ratios approaching Mendelian segregation. Although some degree of gene drive is observed in these mosquitoes, HDR-mediated copying of the AsMCRkh2 cargo is reduced (typically ∼12-25% conversion assayed in larvae and adults; Table 2 ) relative to crosses in which that construct has been propagated with high fidelity via DsRed + /kh w+ parents. The most likely explanation for this difference is that in crosses where the AsMCRkh2-bearing parent is female, Cas9 protein is presumably expressed throughout the cytoplasm of the egg, where it may generate indel mutations via NHEJ that disrupt the gRNA cleavage site and thereby preclude subsequent HDR-mediated copying of the cargo in the germline lineages.
The Antipathogen Effector Genes Are Transcriptionally Active. The m1C3 and 2A10 scFvs are under the control of the blood mealinducible 5′-and 3′-end regulatory elements of the An. gambiae carboxypeptidase A (AgCPA) and An. stephensi Vitellogenin 1 (AsVg1) genes, respectively (11) . Blood meal-induced, tissuespecific accumulations of m1C3 and 2A10 transcripts were observed by RT-PCR analysis of total RNA isolated from G 3 DsRed + /kh w− dissected females and whole males (Fig. 4) . Midgut and carcass (all tissues except the midguts) were collected from females at 0, 4, 12, 24, and 48 h post blood meal (hPBM). The AgCPA promoter driving expression of the m1C3 scFv displays constitutive midgut-specific expression in the absence of a blood meal but increases to a peak at 4 hPBM and falls over the next 2 d, consistent with the endogenous expression profile of the orthologous gene from An. stephensi (10) . Expression of the 2A10 transgene product by the AsVg1 promoter shows induction at 12 hPBM with a qualitative maximum at 24 hPBM in carcasses and an earlier induction in the midgut. Because midgut expression is not a characteristic feature of the endogenous gene (33) , position effects resulting from the insertion site may contribute to this result. As expected, samples from males show no expression from either transgene. These data support the conclusion that the antipathogen effector genes are transcribed in a blood meal-regulated fashion following Cas9-mediated integration. , half-red and half-white circles) or mosaic (DsRed + /mosaic, half-red and half checkered circles) eyes (Table 1) . Among the DsRed − progeny, approximately half had wild-type eyes (all-black circles) and half had white eyes (half-black and half-white circles). Male-derived (G 2 cross) G4 progeny (Left) show a bias of HDR over NHEJ, whereas female-derived (G 2 cross) G 4 progeny lines display nearly equal HDR and NHEJ.
AsVg1-m2A10
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Discussion
The data presented here support the following conclusions: (i) Cas9-mediated gene drive based on a system adapted from MCR works well in a malaria mosquito, An. stephensi; (ii) the gene-drive system is target-specific; (iii) the system works in the germ line of both males and females; (iv) the system is active early in the somatic cells of embryos derived from transgenic females; (v) the gene-drive system can carry a relatively large cargo; and (vi) the cargo is functional (at the transcriptional level). These results provide the basis for the further development of Cas9-mediated gene-drive technology in sustaining malaria control and elimination as part of the eradication agenda. The use of both dominant and recessive marker genes for genedrive function, as well as the choice of promoter for driving the Cas9 activity, has provided a number of insights that can guide the further development of this approach into a functional system for malaria control. The tight linkage of the DsRed marker gene to the antipathogen effector scFvs allows the tracking of the malaria-resistance phenotype by monitoring fluorescence in samples of larvae. This is expected to have significant practical value as this technology continues to be developed for the field. Targeting the kh w gene allowed us to monitor the specificity of Cas9-mediated gene conversion and mutagenesis by scoring the white-eye phenotype. Furthermore, the data presented here provide support for the hypothesis that there is a load associated with the white-eye phenotype (homozygous kh w− ), so this locus may not be optimal for any strain developed for field applications. Other target sites are available in the An. stephensi genome that appear not to have any significant fitness issues (10, 11, 21) , and further validation of the technology may make it unnecessary to target loci with recessive visible phenotypes.
The sex-specific expression of Cas9 mediated by the An. stephensi vasa ortholog control DNA sequences was highly informative for the design of future autonomous gene-drive systems. Previous transgene analysis of the An. gambiae vasa ortholog showed that it is active in both male and female germ-line tissues, and that sex-and tissue-specific enhancer-like sequences could be localized in the promoter and 5′ untranslated regions (5′UTRs) (32) . We chose to use the complete promoter and 5′UTR sequences of the An. stephensi ortholog in our autonomous construct to maximize the potential for germ-line gene conversion via HDR. This allowed us to discover the effects of pre-and postzygotic activity of the Cas9 nuclease and gRNAs and the impact of HDR and NHEJ on subsequent gene drive and inheritance.
Our data support a model in which the gene drive and inheritance of the transgene cargo are optimized in the progeny of transgenic males whose female parent was wild-type (Fig. 5) . Male and female progeny of these males also faithfully transmitted the cargo to their progeny. However, progeny of transgenic males and females whose parent was a transgenic female transmit the cargo in ratios similar to what is expected of Mendelian segregation, although there does appear to be some residual drive. These differences can be understood in terms of a maternal effect of Cas9 expression in the developing embryos. Outcrosses of transgenic male parents to wild-type females result in an embryonic environment in which the eggs lack maternally produced Cas9. Hence, Cas9 expression is restricted to the germ line, where it continues to catalyze high-frequency HDR. In contrast, outcrosses of transgenic female parents to wild-type males produce embryos in which the eggs have active levels of Cas9 and kh2 gRNAs. The wild-type kh w (kh w+ ) allele contributed by the sperm can be subject to Cas9-mediated activity in pre-and postsyncytial blastoderm nuclei before cellularization and partitioning of the germplasm into posterior cells to form the germ line. This early activity could result in either HDR or NHEJ. Given the initial physical separation of the paternally derived kh w+ allele from the maternally derived allele immediately following fertilization, the repair template (the DsRed + , kh w− allele) may be positioned sufficiently far from the Cas9-induced double-stranded break and favor NHEJ. The fact that nearly all progeny from such crosses manifest a white-eye phenotype supports the interpretation that such early-acting mutagenesis occurs at a high frequency. Importantly, once a homologous chromosome has been mutated by NHEJ, key nucleotides required for gRNA recognition will typically be eliminated, thus precluding subsequent HDR-mediated gene conversion in the germ line. This has a dampening effect on drive, and progeny phenotype ratios thus approach Mendelian inheritance. This also explains the rare phenotypes we observed in the female-derived lines. In contrast, zygotes resulting from outcrosses of transgenic females have Cas9 nuclease in the eggs (aqua-colored oval) as a result of vasa-directed expression in the maternal germ line, and this catalyzes nonhomologous end joining (asterisk) to mutate the paternally derived wild-type chromosome (encircled by the dotted line). Some HDR may occur at this stage, but may be hampered by an initial physical separation of the maternal and paternal chromosomes. Embryos derived from transgenic AsMCRkh2 females also have vasa-mediated Cas9 expression restricted to the germ line (colored half-oval), but in addition have the nuclease perduring from the maternal gamete (light-colored half-oval), which can result in adults that are phenotypically positive for the dominant reporter gene, DsRed, and exhibit the white or mosaic eye color. Furthermore, the paternally derived chromosomes mutagenized in the zygotes are resistant to subsequent HDR and insertion of the cargo. Some of the male-derived chromosomes may not be mutagenized, and these can be substrates for HDR. Both options are shown as the asterisk overlying the red bar in the germ line.
Two types of mosaic phenotypes result in those animals where mutagenesis of the kh w locus is not complete. First, patches of wild-type cells visible in the eyes reflect groups of cells in the eye in which there was no mutagenesis. Second, uniform colored-eyed phenotypes may arise as a consequence of the kynurenine hydroxylase enzyme being diffusible throughout the insect (28) , in which case the colored eyes could arise from patches of wild-type cells outside the eye contributing enough enzyme to produce some pigment in the eyes. Alternatively, NHEJ may generate partial loss-of-function alleles whose products synthesize reduced levels of pigment.
An observation that does not have a straightforward explanation is the difference in inheritance seen in the G 2 progeny of the original 10.1 and 10.2 G 1 founder males. One male founder (10.1) transmitted the construct to all of its G 2 progeny, whereas the other (10.2) transmitted the element in a Mendelian fashion. The insertion events of both of these males are precise based on sequencing of junction fragments in genomic DNA. Furthermore, the G 2 progeny of these males efficiently propagated the cargo to G 3 male and female progeny, indicating that both insertional events had functional converting elements. Because DsRed + G 2 10.2 males and females transmitted the cargo at the same high frequency as their G 2 10.1 DsRed + counterparts, the differences in transmission observed between the two G 1 founders did not result in heritable differences in the transgene or its insertion site. It is possible that short-duration epigenetic differences between the two insertional events or differential persistence of injected Cas9 dsRNA may account for the observed transgene inheritance. The recovery of DsRed A number of alternate approaches could mitigate the maternal effects that result in a high frequency of NHEJ and drive-resistant loci. The most straightforward solution is to drive Cas9 with a male germ-line-specific cis-regulatory sequence such as those of the wellcharacterized β2-tubulin gene, which is expressed only in the sperm of dipterans including D. melanogaster (34-36), An. stephensi (37), and Ae. aegypti (38) . Alternatively, it may be possible to reduce the activity of Cas9 in the egg by maternal (but not germ-line) expression of Cas9 and/or Ku70 RNAi constructs. This is similar to the approach applied here for the initial recovery of the AsMCRkh2 transgenic mosquitoes. Advances in CRISPR/Cas9 research also offer potential solutions that greatly reduce the inhibition of HDR by the prior action of NHEJ by exploiting modified nucleases that cleave DNA at a distance from the gRNA recognition sequence, thereby allowing multiple rounds of target mutagenesis without eliminating the gRNA target site (39), or those that are mutated to cleave a single strand, the so-called nicking endonucleases (40) . Autonomous gene-drive constructs using these modified nucleases may be less susceptible to NHEJ alteration of the homologous chromosome, which could then remain an efficient target for subsequent HDR-mediated conversion in the germ line. Future tests of these various strategies should establish those approaches that are the most effective for robust multigenerational maintenance of gene drive.
Gene-drive systems for population modification of vector mosquitoes have been proposed for nearly half a century (41) . The phenomenal rate of allelic conversion achieved is a milestone achievement in the development of population-modification strategies for controlling malaria and other vector-borne diseases. These efforts justify a degree of optimism for the future successful application of this technology. We are fully aware that much needs to be done before laboratory achievements of this type are moved to the field. Effector gene stability in different genetic backgrounds and under diverse environmental conditions and efficacy against genetically diverse parasites need further research to ensure that the constructs function as well in the field as they do in the laboratory. In addition, significant advances in regulatory structures and ethical models of community engagement are as important as the further scientific development of these technologies (7, 42, 43) . It is incumbent on the scientist developing these technologies to interact openly and freely with the potential end users. Finally, we do not believe that these technologies alone will be sufficient for malaria eradication. We support the combined efforts of people developing prophylactic and therapeutic drugs, vaccines, and alternate vector-control measures.
Materials and Methods
Mosquito Rearing and Maintenance. A colony of An. stephensi (15) bred in our insectary for >7 y was used in the experiments. The mosquitoes were maintained at 27°C with 77% humidity and a 12-h day/night, 30-min dusk/ dawn lighting cycle. Larvae were fed a diet of powdered fish food (TetraMin) mixed with yeast. Adults were provided with water and a 10% (wt/vol) sucrose solution ad libitum. Blood meals were provided by artificial feeding or mice. Protocols were approved by the Intuitional Animal Care and Use Committee of the University of California, Irvine (NIH Animal Welfare Assurance no. A3416.01). Mosquito containment followed recommended procedures (44) .
Oligonucleotide Primers. SI Appendix, Table S2 lists oligonucleotide primer names and sequences used for gene amplification.
Design of the Gene-Drive Construct. Standard molecular biological procedures were used to construct the gene-drive plasmid, pAsMCRkh2. Detailed descriptions of the construction and plasmid architecture are provided in SI Appendix, Materials and Methods.
Generation of Double-Stranded RNA. Double-stranded RNA was generated to inhibit the expression of Cas9 from the donor plasmid during microinjection. Previous injections using Cas9 expressed from a plasmid or from Cas9 mRNA were unsuccessful, and we hypothesized that a high amount of Cas9 could be toxic to the embryos. Therefore, a total of 100 ng/μL Cas9 protein was included in the injection mixture along with dsRNA targeting Cas9 mRNA so that Cas9 mRNA generated by expression from the donor plasmid in the embryo would be destroyed and only the injected protein would be present. Additionally, dsRNA was injected targeting the putative ortholog of Ku70, a protein essential for nonhomologous end joining (45, 46) . Knockdown of this protein may increase the possibility of repair by homologous recombination (47, 48) . The putative ortholog for Ku70 in An. stephensi, ASTE011109, was identified by homology to Bombyx mori X-ray repair cross-complementing protein 5-like mRNA (LOC101736121) using the BLAST tool available at VectorBase.org. Primers were designed to amplify a 561-bp region of the ASTE011109 transcript and a 637-bp region of the An. stephensi codonoptimized Cas9, such that the amplicons did not contain >19 bp of identity to any other putative transcript available on VectorBase to avoid off-target effects. Both forward and reverse primers have T7 promoters at the 5′ end. The amplification products were purified using DNA Clean & Concentrator (Zymo) and used as a template for reverse transcription using the RNAi Kit from Ambion.
Microinjection and Screening Procedures. Microinjections were performed as described previously (10) . Embryos were injected with a solution containing 100 ng/μL each of the plasmid, pAsMCRkh2, Cas9 protein, Cas9 dsRNA, and Ku70 dsRNA. G 0 males and females were outcrossed to wild-type mosquitoes in pools of ∼5 G 0 males or 15-30 G 0 females. All G 1 , G 2 , G 3 , and G 4 progeny were screened as larvae for DsRed fluorescence under UV-fluorescence microscopy, and adults were screened under light microscopy.
RT-PCR. RT-PCR analyses were adapted from those used in ref. 11 with an additional RNA purification with Zymo RNA Clean & Concentrator. A total of 15 males and 30 female carcasses and dissected midguts from mixed heterozygous and homozygous DsRed + G 3 mosquitoes was used for each RNA preparation. Two hundred nanograms of DNase-treated total RNA was used in each reaction.
